FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013670789> ?p ?o ?g. }

• W3013670789 endingPage "134" @default.
• W3013670789 startingPage "127" @default.
• W3013670789 abstract "In 2019, an important inflection point occurred when the U.S. Food and Drug Administration approved three new antibody-drug conjugates (ADCs) for the treatment of malignancies, including urothelial cancer (enfortumab vedotin-ejfv), diffuse large B-cell lymphoma (polatuzumab vedotin-piiq), and HER2 breast cancer (fam-trastuzumab deruxtecan-nxki), and expanded the indication for ado-trastuzumab emtansine to early breast cancer. This near doubling in the number of approved ADCs within 1 year validates the ADC platform and represents a successful evolution over the past 30 years. ADCs were born in an era when systemic therapy for cancer was largely cytotoxic chemotherapy. Many of the investigational cytotoxic agents were determined to be too toxic for oral and intravenous use. The agents were especially potent, with inhibitory concentrations that inhibited 50% of cells in the nanomolar and picomolar range but had poor therapeutic indexes when administered systemically. Now, over the last 30 years, we have seen an evolution of the many aspects of this complex platform with better antigen target selection, more sophisticated chemistry for the linkers, a growing diversity of payloads from cytotoxic chemotherapy to targeted therapies and immunostimulants, and, with the recent series of regulatory approvals, a buoyed sense of optimism for the technology. Nonetheless, we have not fully realized the full potential of this platform. In this review, the many components of ADCs will be discussed, the difficulties encountered will be highlighted, the innovative strategies that are being used to improve them will be assessed, and the direction that the field is going will be considered." @default.
• W3013670789 created "2020-04-03" @default.
• W3013670789 creator A5060992997 @default.
• W3013670789 date "2020-05-01" @default.
• W3013670789 modified "2023-10-11" @default.
• W3013670789 title "The Evolution of Antibody-Drug Conjugates: A Positive Inflexion Point" @default.
• W3013670789 cites W1521126454 @default.
• W3013670789 cites W1670498114 @default.
• W3013670789 cites W1832002274 @default.
• W3013670789 cites W1947496848 @default.
• W3013670789 cites W1977301054 @default.
• W3013670789 cites W1992880310 @default.
• W3013670789 cites W2004561542 @default.
• W3013670789 cites W2010442254 @default.
• W3013670789 cites W2011733413 @default.
• W3013670789 cites W2016511744 @default.
• W3013670789 cites W2043028214 @default.
• W3013670789 cites W2043970203 @default.
• W3013670789 cites W2054114326 @default.
• W3013670789 cites W2075305667 @default.
• W3013670789 cites W2093215461 @default.
• W3013670789 cites W2106071154 @default.
• W3013670789 cites W2107587681 @default.
• W3013670789 cites W2121080375 @default.
• W3013670789 cites W2126183505 @default.
• W3013670789 cites W2133029659 @default.
• W3013670789 cites W2140259056 @default.
• W3013670789 cites W2143869160 @default.
• W3013670789 cites W2150244588 @default.
• W3013670789 cites W2162999937 @default.
• W3013670789 cites W2194989239 @default.
• W3013670789 cites W2220679566 @default.
• W3013670789 cites W2277737065 @default.
• W3013670789 cites W2338405699 @default.
• W3013670789 cites W2341089209 @default.
• W3013670789 cites W2416202632 @default.
• W3013670789 cites W2526956956 @default.
• W3013670789 cites W2529226476 @default.
• W3013670789 cites W2531217210 @default.
• W3013670789 cites W2531611585 @default.
• W3013670789 cites W2549780925 @default.
• W3013670789 cites W2560431464 @default.
• W3013670789 cites W2593197196 @default.
• W3013670789 cites W2597045666 @default.
• W3013670789 cites W2614773797 @default.
• W3013670789 cites W2745564410 @default.
• W3013670789 cites W2767025650 @default.
• W3013670789 cites W2793463849 @default.
• W3013670789 cites W2804069829 @default.
• W3013670789 cites W2899156851 @default.
• W3013670789 cites W2916615865 @default.
• W3013670789 cites W2931729368 @default.
• W3013670789 cites W2946972740 @default.
• W3013670789 cites W2973098277 @default.
• W3013670789 cites W2991390941 @default.
• W3013670789 cites W2996630100 @default.
• W3013670789 cites W3004183788 @default.
• W3013670789 cites W4249056559 @default.
• W3013670789 doi "https://doi.org/10.1200/edbk_281103" @default.
• W3013670789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32223669" @default.
• W3013670789 hasPublicationYear "2020" @default.
• W3013670789 type Work @default.
• W3013670789 sameAs 3013670789 @default.
• W3013670789 citedByCount "22" @default.
• W3013670789 countsByYear W30136707892020 @default.
• W3013670789 countsByYear W30136707892021 @default.
• W3013670789 countsByYear W30136707892022 @default.
• W3013670789 countsByYear W30136707892023 @default.
• W3013670789 crossrefType "journal-article" @default.
• W3013670789 hasAuthorship W3013670789A5060992997 @default.
• W3013670789 hasBestOaLocation W30136707891 @default.
• W3013670789 hasConcept C121608353 @default.
• W3013670789 hasConcept C126322002 @default.
• W3013670789 hasConcept C143998085 @default.
• W3013670789 hasConcept C154317977 @default.
• W3013670789 hasConcept C159654299 @default.
• W3013670789 hasConcept C185592680 @default.
• W3013670789 hasConcept C202751555 @default.
• W3013670789 hasConcept C203014093 @default.
• W3013670789 hasConcept C2777325958 @default.
• W3013670789 hasConcept C2778087150 @default.
• W3013670789 hasConcept C2779786085 @default.
• W3013670789 hasConcept C2780035454 @default.
• W3013670789 hasConcept C502942594 @default.
• W3013670789 hasConcept C530470458 @default.
• W3013670789 hasConcept C542903549 @default.
• W3013670789 hasConcept C55493867 @default.
• W3013670789 hasConcept C71924100 @default.
• W3013670789 hasConcept C98274493 @default.
• W3013670789 hasConceptScore W3013670789C121608353 @default.
• W3013670789 hasConceptScore W3013670789C126322002 @default.
• W3013670789 hasConceptScore W3013670789C143998085 @default.
• W3013670789 hasConceptScore W3013670789C154317977 @default.
• W3013670789 hasConceptScore W3013670789C159654299 @default.
• W3013670789 hasConceptScore W3013670789C185592680 @default.
• W3013670789 hasConceptScore W3013670789C202751555 @default.
• W3013670789 hasConceptScore W3013670789C203014093 @default.
• W3013670789 hasConceptScore W3013670789C2777325958 @default.

• next